Authors: FUKUSHIMA M SATAKE H UCHIDA J SHIMAMOTO Y KATO T TAKECHI T OKABE H FUJIOKA A NAKANO K OHSHIMO H TAKEDA S SHIRASAKA T

Citation: M. Fukushima et al., PRECLINICAL ANTITUMOR EFFICACY OF S-L - A NEW ORAL FORMULATION OF 5-FLUOROURACIL ON HUMAN TUMOR XENOGRAFTS, International journal of oncology, 13(4), 1998, pp. 693-698

Authors: FUKUSHIMA M SHIMAMOTO Y KATO T UCHIDA J YONEKURA R OHSHIMO H SHIRASAKA T

Citation: M. Fukushima et al., ANTICANCER ACTIVITY AND TOXICITY OF S-1, AN ORAL COMBINATION OF TEGAFUR AND 2 BIOCHEMICAL MODULATORS, COMPARED WITH CONTINUOUS IV INFUSION OF 5-FLUOROURACIL, Anti-cancer drugs, 9(9), 1998, pp. 817-823

Authors: KURIHARA M UCHIDA J FUJIOKA A KATO T OHSHIMO H ABE M TAKEDA S FUKUSHIMA M

Citation: M. Kurihara et al., EFFECT OF COMBINATION THERAPY WITH UFT-PLUS-CISPLATIN (UFTP) ON THE SURVIVAL OF MICE IN THE EXPERIMENTAL-MODEL FOR WIDE-SPREAD METASTASIS IN THE PERITONEAL-CAVITY OF GASTROINTESTINAL-CANCER USING COLON-26-PMF-15-CELLS, Anticancer research, 17(3C), 1997, pp. 2217-2220

Authors: SHIRASAKA T SHIMAMATO Y OHSHIMO H YAMAGUCHI M KATO T YONEKURA K FUKUSHIMA M

Citation: T. Shirasaka et al., DEVELOPMENT OF A NOVEL FORM OF AN ORAL 5-FLUOROURACIL DERIVATIVE (S-1) DIRECTED TO THE POTENTIATION OF THE TUMOR SELECTIVE CYTOTOXICITY OF 5-FLUOROURACIL BY 2 BIOCHEMICAL MODULATORS, Anti-cancer drugs, 7(5), 1996, pp. 548-557

Authors: SHIRASAKA T SHIMAMOTO Y OHSHIMO H SAITO H FUKUSHIMA M

Citation: T. Shirasaka et al., METABOLIC BASIS OF THE SYNERGISTIC ANTITUMOR ACTIVITIES OF 5-FLUOROURACIL AND CISPLATIN IN RODENT TUMOR-MODELS INVIVO, Cancer chemotherapy and pharmacology, 32(3), 1993, pp. 167-172